HPV Vaccine Optimization Strategies for Human Papillomavirus
Trial Summary
The trial does not involve individual participants taking medications, as it focuses on clinics and their staff. Therefore, there is no requirement for individuals to stop taking their current medications.
Research in oncology shows that communication skills training for healthcare providers improves their communication abilities, increases patient satisfaction, and reduces patient anxiety. These findings suggest that similar training could enhance communication about HPV vaccination, potentially leading to better patient understanding and increased vaccination rates.
12345Eligibility Criteria
This trial is for primary care clinics that vaccinate children aged 9-12 against HPV but have vaccination rates below 72%. Clinics must have standing orders for the vaccine, which they either don't use routinely or are willing to adopt. Staff must complete a follow-up survey. Children and clinics not meeting these criteria are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Clinics receive communication training and tools for optimizing HPV vaccine standing orders
Follow-up
Clinics are monitored for changes in HPV vaccination rates and implementation of standing orders